Sebastian Hoehl

2.5k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Sebastian Hoehl is a scholar working on Infectious Diseases, Biomedical Engineering and Modeling and Simulation. According to data from OpenAlex, Sebastian Hoehl has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 7 papers in Biomedical Engineering and 6 papers in Modeling and Simulation. Recurrent topics in Sebastian Hoehl's work include SARS-CoV-2 and COVID-19 Research (21 papers), SARS-CoV-2 detection and testing (15 papers) and COVID-19 Clinical Research Studies (12 papers). Sebastian Hoehl is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (21 papers), SARS-CoV-2 detection and testing (15 papers) and COVID-19 Clinical Research Studies (12 papers). Sebastian Hoehl collaborates with scholars based in Germany and Ireland. Sebastian Hoehl's co-authors include Sandra Ciesek, Annemarie Berger, Holger F. Rabenau, Tuna Toptan, Niko Kohmer, Marek Widera, Timo Wolf, Denisa Bojková, Jindřich Činátl and Sandra Westhaus and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Sebastian Hoehl

32 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

2022 109 citations Alexander Wilhelm, Marek Widera et al. profile →

Peers

Countries citing papers authored by Sebastian Hoehl

Since Specialization

Citations

This map shows the geographic impact of Sebastian Hoehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Hoehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Hoehl more than expected).

Fields of papers citing papers by Sebastian Hoehl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Hoehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Hoehl. The network helps show where Sebastian Hoehl may publish in the future.

Co-authorship network of co-authors of Sebastian Hoehl

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Hoehl. A scholar is included among the top collaborators of Sebastian Hoehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Hoehl. Sebastian Hoehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing GPT and DeepL for terminology translation in the medical domain: A comparative study on the human phenotype ontology 2025 ·BMC Medical Informatics and Decision Making ·(unknown), (unknown), (unknown), (unknown), Ferdinand O. Bohmann, (unknown), (unknown), (unknown), Sebastian Hoehl, (unknown), Jan‐Niklas Eckardt, Holger Storf, Jannik Schaaf	1
2	Translation of Ontological Concepts from English into German Using Commercial Translation Software and Expert Evaluation 2024 ·Studies in health technology and informatics ·(unknown), (unknown), (unknown), (unknown), Michael Wagner, Sebastian Hoehl, (unknown), Holger Storf, Jannik Schaaf	3
3	Pediatric cancer patients vaccinated against SARS-CoV-2—a clinical and laboratory follow-up 2024 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), Andreas Boldt, (unknown), Ulrich Sack, (unknown), Christian Jassoy, Jan‐Henning Klusmann, Sandra Ciesek, Sebastian Hoehl, Thomas Lehrnbecher	0
4	Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis 2023 ·Journal of Clinical Medicine ·Christiana Graf, (unknown), Katharina Grikscheit, Sebastian Hoehl, Annemarie Berger, Nils Wetzstein, Julia Dietz, G. Dultz, (unknown), Natalie Filmann, Eva Herrmann, Peter Tinnemann, Udo Goetsch, Sandra Ciesek	1
5	First description of congenital toxoplasmosis after maternal coinfection with Toxoplasma gondii and severe acute respiratory syndrome coronavirus 2: a case report 2023 ·Journal of Medical Case Reports ·Vu Thao-Vi Dao, (unknown), Rolf Schlößer, Ulrich Rochwalsky, Uwe Groß, Sebastian Hoehl, Volkhard A. J. Kempf, Silke Besier	2
6	Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes 2022 ·Science Immunology ·Jasmin Quandt, Alexander Muik, (unknown), Bonny Gaby Lui, (unknown), (unknown), Ann-Kathrin Wallisch, Petra Adams‐Quack, Maren Bacher, Andrew Finlayson, Orkun Ozhelvaci, Isabel Vogler, Katharina Grikscheit, Sebastian Hoehl, Udo Goetsch, Sandra Ciesek, Özlem Türeci, Uğur Şahin	111
7	Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination 2022 ·Vaccines ·Katharina Grikscheit, Holger F. Rabenau, (unknown), Marek Widera, Alexander Wilhelm, Tuna Toptan, Sebastian Hoehl, (unknown), Fabian Helfritz, Sandra Ciesek	4
8	Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 2022 ·Science Immunology ·Alexander Muik, Bonny Gaby Lui, Maren Bacher, Ann-Kathrin Wallisch, Aras Toker, Andrew Finlayson, (unknown), Orkun Ozhelvaci, Katharina Grikscheit, Sebastian Hoehl, Sandra Ciesek, Özlem Türeci, Uğur Şahin	45
9	SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach 2022 ·International Journal of Infectious Diseases ·(unknown), Sebastian Hoehl, Marek Widera, Denisa Bojková, (unknown), René Gottschalk, (unknown), (unknown), Sandra Ciesek, Udo Goetsch	5
10	Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer 2022 ·Clinical Infectious Diseases ·Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, Andreas H. Groll, Andreas Boldt, (unknown), Simone Hettmer, (unknown), (unknown), Barbara Schenk, Sandra Ciesek, Jan‐Henning Klusmann, Christian Jassoy, Sebastian Hoehl	11
11	Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro 2021 ·The Journal of Infectious Diseases ·Marek Widera, Alexander Wilhelm, Sebastian Hoehl, Christiane Pallas, Niko Kohmer, Timo Wolf, Holger F. Rabenau, Victor M. Corman, Christian Drosten, Maria J. G. T. Vehreschild, Udo Goetsch, René Gottschalk, Sandra Ciesek	43
12	Pediatrics and COVID-19 2021 ·Advances in experimental medicine and biology ·Tuna Toptan, Sandra Ciesek, Sebastian Hoehl	4
13	Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs) 2021 ·Journal of Virological Methods ·Niko Kohmer, Holger F. Rabenau, Sebastian Hoehl, Marhild Kortenbusch, Sandra Ciesek, Annemarie Berger	19
14	A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated 2021 ·Vaccine ·Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker	2
15	Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings 2021 ·Medical Microbiology and Immunology ·Marek Widera, Sandra Westhaus, Holger F. Rabenau, Sebastian Hoehl, Denisa Bojková, Jindřich Činátl, Sandra Ciesek	26
16	Novel multiple swab method enables high efficiency in SARS‐CoV ‐2 screenings without loss of sensitivity for screening of a complete population 2020 ·Transfusion ·Michael Schmidt, Sebastian Hoehl, Annemarie Berger, Heinz Zeichhardt, (unknown), Sandra Ciesek, Erhard Seifried	23
17	Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany 2020 ·Clinical Infectious Diseases ·Sebastian Hoehl, (unknown), Barbara Schenk, Sandra Westhaus, Ivo Foppa, Eva Herrmann, (unknown), (unknown), Alexander Schaible, (unknown), Holger F. Rabenau, Annemarie Berger, Sandra Ciesek	10
18	Die Virologie von SARS-CoV-2 2020 ·Der Pneumologe ·Sebastian Hoehl, Sandra Ciesek	4
19	Die Virologie von SARS-CoV-2 2020 ·Der Gastroenterologe ·Sebastian Hoehl, Sandra Ciesek	1
20	Die Virologie von SARS-CoV-2 2020 ·Der Internist ·Sebastian Hoehl, Sandra Ciesek	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact